Dyne Therapeutics Inc (DYN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -446,214 | -317,418 | -235,937 | -168,099 | -149,291 |
| Depreciation Amortization | 214 | -1,931 | 571 | 2,959 | 3,668 |
| Accounts payable and accrued liabilities | 8,251 | -8,955 | 22,970 | -1,235 | 13,702 |
| Other Working Capital | -3,404 | -19,491 | 26,307 | -5,379 | 9,256 |
| Other Operating Activity | 37,946 | 55,426 | -2,069 | 18,109 | 3,102 |
| Operating Cash Flow | $-403,207 | $-292,369 | $-188,158 | $-153,645 | $-119,563 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -180,534 | -317,443 | -44,262 | -121,176 | -236,721 |
| PPE Investments | -1,920 | -2,376 | -729 | -3,067 | -3,618 |
| Purchase Of Investment | 154,642 | 105,180 | 126,473 | 208,291 | 98,010 |
| Sale Of Investment | 17,851 | 10,563 | 1,829 | 3,154 | 4,437 |
| Other Investing Activity | -18,790 | 0 | 0 | 0 | 0 |
| Investing Cash Flow | $-28,751 | $-204,076 | $83,311 | $87,202 | $-137,892 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 148,256 | N/A | N/A | N/A | N/A |
| Common Stock Issued | 742,609 | 809,895 | 54,322 | 37,390 | 157,821 |
| Other Financing Activity | -558 | 0 | 0 | 0 | 0 |
| Financing Cash Flow | $890,307 | $809,895 | $54,322 | $37,390 | $157,821 |
| Beginning Cash Position | 437,391 | 123,941 | 174,466 | 203,519 | 303,153 |
| End Cash Position | 895,740 | 437,391 | 123,941 | 174,466 | 203,519 |
| Net Cash Flow | $458,349 | $313,450 | $-50,525 | $-29,053 | $-99,634 |
| Free Cash Flow | |||||
| Operating Cash Flow | -403,207 | -292,369 | -188,158 | -153,645 | -119,563 |
| Capital Expenditure | -1,920 | -2,376 | -729 | -3,067 | -3,618 |
| Free Cash Flow | -405,127 | -294,745 | -188,887 | -156,712 | -123,181 |